Full Paper
[17]
[18]
13
ethane-1,2-diamine, and (S)-2-amino-2-phenylacetamide were
(s, 2H); C NMR (125 MHz, CDCl ): d=10.0, 11.0, 23.2, 23.7, 29.4,
3
prepared as reported previously. All others chemicals are commer-
29.8, 31.1, 31.4, 34.2, 35.2, 35.4, 76.6, 77.4, 118.4, 118.5, 119.3, 122.3,
123.6, 125.3, 126.8, 127.0, 127.7, 128.3, 128.4, 128.8, 129.3, 131.2,
133.2, 134.4, 135.6, 137.4, 138.2, 138.7, 139.5, 142.1, 155.4, 157.4,
160.0, 160.3, 162.8, 176.0 ppm; HRMS (ESI+, MeOH): m/z calcd for
C116H133O N : 1710.0118; found: 1710.0064.
1
cially available from Aldrich and were used as received. H NMR
1
3
and C NMR spectra were recorded on Bruker Avance 500 NMR
spectrometers at 297 K. Chemical shifts are reported in ppm rela-
tive to the residual solvent peaks in CDCl3 (d=7.26 ppm) and
8
4
[
D ]DMSO (d=2.50 ppm). Mass analyses were carried out by the
6
Bis-(4,6-di-tert-butylphenol-salphen)calix[4]arene zinc complex
1): Under an argon atmosphere, compound B-1 (100 mg,
.059 mmol) was dissolved in dry THF (10 mL), and then a solution
High Resolution Mass Spectrometry Unit at the ICIQ in Tarragona,
Spain. UV/Vis and CD spectra were recorded on an Applied Photo-
physics Circular Dichroism Chirascan Spectrophotometer using
host 1 at 6ꢁ10 m in DCM, using the following parameters: step-
size 2 nm, time-per-point 0.5 s, 3 repeats per sample, T=248C. Fur-
ther details are mentioned in each respective section provided
below.
(
0
of ZnEt (1m, 0.12 mL, 0.118 mmol) was added dropwise and the
2
ꢀ
5
reaction mixture was stirred for 4 h. The solvent was then removed
by evaporation to afford 1 as a bright orange solid (yield: 83%).
1
H NMR (500 MHz, DMSO): d=0.91 (t, J=7.5 Hz, 6H), 1.02 (s, 18H),
1
4
4
2
2
9
2
.09–1.15 (m, 24H), 1.45 (s, 18H), 1.83–1.90 (m, 4H), 1.95–2.03 (m,
H), 3.22–3.26 (m, 4H), 3.62–3.68 (m, 4H), 4.01–4.07 (m, 4H), 4.38–
.45 (m, 4H), 4.94 (s, 4H), 6.21–6.28 (m, 8H), 6.33 (d, J=6.7 Hz,
H), 6.48 (d, J=7.9 Hz, 2H), 6.57–6.81 (m, 4H), 7.07 (t, J=8.0 Hz,
H), 7.23–7.28 (m, 4H), 7.37–7.45 (m, 10H), 7.56–7.69 (m, 4H),
Syntheses
Precursor (3,5-di-tert-butyl-2-hydroxyphenyl)(phenyl)methanone
(
13
.04 ppm (s, 2H); C NMR (125 MHz, DMSO): d=10.0, 11.0, 22.8,
3.3, 29.6, 29.8, 30.3, 31.3, 33.6, 35.0, 35.3, 35.6, 76.1, 77.0, 114.7,
A): Under an argon atmosphere, 3,5-di-tert-butylsalicylic acid
(
1.0 g, 4 mmol) was dissolved in dry THF (30 mL). A phenyllithium
115.9, 119.1, 119.7, 121.9, 125.5, 126.0, 126.4, 127.3, 127.6, 128.0,
solution (1.8m in dibutyl ether, 13 mL, 25 mmol) was added drop-
wise at 08C. The solution was then stirred at 108C for 18 h. Then,
freshly distilled Me SiCl (7 mL, 56 mmol) was added, and the reac-
tion mixture was stirred for 1 h. Dilute aqueous HCl (3m, 30 mL)
was then added, and the organic phase was extracted with diethyl
ether (3ꢁ30 mL) and the combined extracts were dried over
Na SO . The product was purified by column chromatography
1
1
1
28.2, 128.5, 129.0, 132.0, 132.9, 134.9, 136.5, 136.8, 140.2, 140.3,
40.7, 141.2, 141.7, 155.0, 156.0, 159.6, 162.9, 170.1, 171.4, 174.2,
75.8 ppm; HRMS (MALDI+, dctb): m/z calcd for C116H O N Zn
2
3
130
8
4
+
(M+2H) : 1836.8628; found: 1836.8772.
5-Mono-[1-(3-tert-butyl-2-hydroxy-1-formylphenyl)]-25,26,27,26-
2
4
tetra-propoxy-calix[4]arene (B-2): Under an argon atmosphere,
Pd(OAc)2 (10 mg, 0.045 mmol) and P(o-tol)3 (27 mg, 0.089 mmol)
were dissolved in previously deoxygenated toluene (25 mL). After
(
5:95 up to 10:90 v/v ethyl acetate/hexane) to give A as a yellow
1
solid (yield: 92%). H NMR (500 MHz, CDCl ): d=1.25 (s, 9H), 1.49
3
(
s, 9H), 7.44 (d, J=2.4 Hz, 2H), 7.71–7.48 (m, 5H), 12.71 ppm (s,
stirring the mixture for 30 min, mono-5-bromotetrapropoxycalix[4]-
1
3
[15]
1
1
2
3
H); C NMR (125 MHz, CDCl ): d=29.6, 31.4, 34.4, 35.4, 118.2,
arene (500 mg, 0.74 mmol)
and 3-(tert-butyl)-2-hydroxy-5-
3
28.0, 128.3, 129.4, 131.4, 131.7, 138.0, 138.9, 140.0, 160.1,
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde (268 mg,
[16]
02.7 ppm; HRMS (ESI+, MeOH): m/z calcd for C H O Na:
0.89 mmol) were dissolved in deoxygenated MeOH (5 mL) and
2
1
26
2
33.1825; found: 333.1828.
added to the mixture with an aqueous solution of K CO (2m,
2
3
5
mL). After 40 h stirring at 658C, the reaction mixture was allowed
Precursor (E)-2-{[(2-aminophenyl)imino]-(phenyl)methyl}-4,6-di-
tert-butylphenol (B): Compound A (300 mg, 0.88 mmol) was dis-
solved in toluene (20 mL) and o-phenylenediamine (191 mg,
to cool and water (10 mL) and aqueous HCl (1m, 5 mL) were
added. The crude product was filtered through Celite and extract-
ed with ethyl acetate (3ꢁ30 mL). The organic phases were com-
1
.76 mmol) and p-toluenesulfonic acid (8 mg, 0.09 mmol) were
bined and dried over Na SO . The solvent was removed by evapo-
added to the mixture. The reaction was performed using a Dean–
Stark apparatus (120–1308C) for 30 h. The reaction mixture was al-
lowed to cool and the resultant precipitate was filtered off and
2
4
ration and the white solid obtained was further triturated with
1
MeOH to give B-2 (yield: 71%). H NMR (500 MHz, CDCl ): d=0.95
3
(
t, J=7.4 Hz, 6H), 1.04 (t, J=7.4 Hz, 3H), 1.07 (t, J=7.4 Hz, 3H),
washed with MeOH (3ꢁ10 mL) to give B as a yellow solid (yield:
1
1
1
3
(
7
.40 (s, 9H), 1.86–2.01 (m, 8H), 3.15 (d, J=13.4 Hz, 2H), 3.20 (d, J=
3.4 Hz, 2H), 3.76 (t, J=7.1 Hz, 2H), 3.81 (t, J=7.1 Hz, 2H), 3.91–
.98 (m, 4H), 4.46 (d, J=13.4 Hz, 2H), 4.50 (d, J=13.4 Hz, 2H), 6.06
7
4%). H NMR (500 MHz, CDCl ): d=1.15 (s, 9H), 1.51 (s, 9H), 3.84
3
(
s, 2H), 6.27 (dd, J=1.5 Hz; 8.0 Hz, 1H), 6.40 (td, J=1.4 Hz; 7.6 Hz,
1
1
7
H), 6.67 (dd, J=1.4 Hz; 8.0 Hz, 1H), 6.81 (td, J=1.5 Hz; 7.6 Hz,
H), 6.96 (d, J=2.5 Hz, 1H), 7.17–7.23 (m, 2H), 7.30–7.34 (m, 3H),
.46 (d, J=2.5 Hz, 1H), 14.90 ppm (s, 1H); C NMR (125 MHz,
t, J=7.5 Hz, 1H), 6.31 (d, J=7.5 Hz, 2H), 6.51 (s, 2H), 6.74 (t, J=
13
.5 Hz, 2H), 6.85 (d, J=7.5 Hz, 2H), 6.89 (d, J=7.5 Hz, 2H), 7.22 (d,
13
J=7.5 Hz, 2H), 9.86 (s, 1H), 11.65 ppm (s. 1H); C NMR (125 MHz,
CDCl ): d=10.3, 10.7, 23.3, 23.5, 23.6, 29.4, 29.8, 31.1, 31.3, 35.0,
7
1
1
CDCl ): d=29.7, 31.4, 34.3, 35.4, 115.2, 118.1, 119.0, 122.2, 125.6,
3
1
1
27.0, 128.1, 128.3, 128.5, 129.1, 134.2, 135.1, 136.7, 137.4, 139.1,
39.4, 159.9, 176.2 ppm; HRMS (ESI+, MeOH): m/z calcd for
3
7.0, 77.1, 77.4, 120.6, 121.8, 122.0, 126.2, 127.7, 128.7, 128.8, 129.7,
32.9, 133.4, 133.7, 134.4, 134.9, 136.0, 136.3, 138.0, 155.8, 156.1,
57.4, 160.0, 197.5 ppm; HRMS (ESI+, MeOH): m/z calcd for
C H ON : 401.2587; found: 401.2584.
2
7
33
2
Bis-(4,6-di-tert-butylphenol-salphen)calix[4]arene ligand (B-1):
Compounds A-1 (150 mg, 0.16 mmol) and B (134 mg, 0.33 mmol)
C H O Na: 791.4282; found: 791.4281.
51
60
6
were dissolved in a 50:50 v/v MeOH/CHCl solvent mixture (10 mL).
5-Mono-(4,6-di-tert-butylphenol-salphen)calix[4]arene ligand (C-
2): Compounds B-2 (100 mg, 0.13 mmol) and B (78 mg, 0.20 mmol)
were dissolved in a 1:1 v/v MeOH/CHCl3 solvent mixture (5 mL).
The reaction mixture was stirred and heated at reflux for 30 h, after
which TLC showed full consumption of the aldehyde reagent. The
solvent was then removed by evaporation to afford a yellow solid,
3
The reaction mixture was heated at reflux for 48 h (until all alde-
hyde had been consumed, as monitored by TLC). The solvent was
then removed by evaporation to afford a yellow solid, which was
washed and triturated with MeOH to give B-1 (yield: 70%).
1
H NMR (500 MHz, CDCl ): d=0.88–1.00 (m, 12H), 1.11 (s, 18H),
3
1
1.36 (s, 18H), 1.53 (s, 18H), 1.84–2.03 (m, 8H), 3.23 (d, J=13.5 Hz,
4H), 3.66–3.80 (m, 4H), 3.99–4.12 (m, 4H), 4.52 (d, J=13.0 Hz, 4H),
6.16–6.35 (m, 8H), 6.86–6.92 (m, 2H), 7.03–7.33 (m, 18H), 7.46 (d,
which was triturated with MeOH to give C-2 (yield: 62%). H NMR
(500 MHz, CDCl ): d=0.96 (t, J=7.4 Hz, 6H), 1.01–1.06 (m, 6H),
3
1.09 (s, 9H), 1.27 (s, 9H), 1.51 (s, 9H), 1.86–1.98 (m, 8H), 3.17 (dd,
J=9.5 Hz, 4H), 7.63 (s, 2H), 8.53 (s, 2H), 13.88 (s, 2H), 14.70 ppm
J=6.7 Hz; 13.5 Hz, 4H), 3.78 (t, J=7.3 Hz, 2H), 3.83 (t, J=7.3 Hz,
Chem. Eur. J. 2015, 21, 1 – 8
5
ꢂ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
&
These are not the final page numbers! ÞÞ